Key Trend Reshaping the Next-Generation Sequencing Data Analysis Market in 2025: Advancements In Bioinformatics Software Revolutionize NGS Data Analysis For Clinical And Research Applications

How Are the key drivers contributing to the expansion of the next-generation sequencing data analysis market?
The rising incidence of cancer is anticipated to spike the expansion of the next-generation sequencing data analysis market. Cancer is a set of diseases defined by the unregulated proliferation and distribution of abnormal cells within the body, potentially leading to severe health issues or death if left untreated. Unhealthy lifestyle choices, such as smoking, heavy drinking, and consumption of processed food while neglecting fruits and vegetables, can drastically raise the chances of developing cancer. The next-generation sequencing data analysis contributes to cancer treatment by accurately detecting genetic mutations. This leads to customized therapies and more successful treatment approaches designed based on the unique genetic makeup of a person's cancer. For example, the World Health Organization, a Switzerland-based intergovernmental organization, predicted in February 2024 that by 2050, there would be more than 35 million new instances of cancer. This reflects a 77% rise compared to the projected 20 million cases in 2022. Hence, the escalating prevalence of cancer is pushing the growth of the next-generation sequencing data analysis market.

Get Your Next-Generation Sequencing Data Analysis Market Report Here:
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-data-analysis-global-market-report

What growth opportunities are expected to drive the next-generation sequencing data analysis market's CAGR through 2034?
The market size of next-generation sequencing data analysis has seen a substantial growth in the past few years. Its growth is anticipated to rise from $1.21 billion in 2024 to $1.48 billion in 2025, with an expected compound annual growth rate (CAGR) of 22.0%. The notable growth observed during the period in history can be linked to its increasing use in pathogen detection, its adoption in the research and diagnostics of veterinary practices, its escalating usage in identifying rare genetic disorders, the heightened focus on microbiome research, as well as the expanded use of NGS in the field of pharmacogenomics.

Anticipations are set for a massive expansion in the market size of next-generation sequencing data analysis in the upcoming years, with the estimates pegging it at $3.24 billion by 2029, growing at a compounded annual growth rate of 21.7%. This substantial growth in the prediction phase can be attributed to factors such as growing interest in incorporating genomics into healthcare, educating healthcare workers, enhanced focus on public health monitoring, reducing the costs of sequencing, and increased interest in epigenetic studies. Major trends of the prediction phase encompass the advancements in single-cell sequencing, automation in NGS data analysis, progress in visualization tools for NGS data, utilization of blockchain technology, and enhancement in hybrid sequencing techniques.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19614&type=smp

What are the emerging trends shaping the future of the next-generation sequencing data analysis market?
Leading organizations in the next-generation sequencing data analysis field are directing their efforts towards creating advanced secondary analysis bioinformatics software. This focus stems from the need for faster and more accurate detection of genetic variations for both research and clinical uses. Secondary analysis bioinformatics software takes on the task of transforming raw sequencing information from next-generation sequencing (NGS) into comprehensible formats, such as variant call files (VCF) that explain genetic changes. This type of software simplifies NGS data analysis for research and clinical needs. For example, in January 2024, QIAGEN Digital Insights, an American bioinformatics branch of QIAGEN, introduced the QIAGEN CLC Genomics Workbench Premium equipped with LightSpeed technology. This software aids in next-generation sequencing (NGS) for somatic cancer analysis and rapidly processes whole genome sequencing (WGS) samples. It has the capability to analyze 34x human genomes in just 25 minutes and 50x exomes in 90 seconds using LightSpeed technology, able to efficiently adapt raw FASTQ data into comprehensible layouts. Prices for this program start as low as $1 for genomes and a few cents for exomes leveraging a cloud infrastructure, thus it presents an economical solution for high-throughput laboratories. This software is compatible with typical hardware or cloud platforms offering flexibility coupled with utmost accuracy, which makes it a preferred choice for clinical use and also helps to reduce its carbon footprint.

Which growth-oriented segments of the next-generation sequencing data analysis market are leading the industry's development?
The next-generation sequencing data analysismarket covered in this report is segmented -

1) By Product: Services, Next-Generation Sequencing (NGS) Commercial Software
2) By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing
3) By Mode: In-House, Outsourced
4) By Workflow: Primary, Secondary, Tertiary
5) By End-User: Academic Research, Clinical Research, Hospitals And Clinics, Pharma And Biotech Entities, Other End-Users

Subsegments:
1) By Services: Data Analysis Services, Bioinformatics Services, Consulting Services, Sample Preparation Services, Training and Support Services
2) By Next-Generation Sequencing (NGS) Commercial Software: Data Management Software, Alignment Software, Variant Calling Software, Visualization Software, Pipeline Management Software, Specialized Analysis Software

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19614

What regions are leading the charge in the next-generation sequencing data analysis market?
North America was the largest region in the next-generation sequencing data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the next-generation sequencing data analysis market?
Major companies operating in the next-generation sequencing data analysis market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., MedGenome Inc., Element Biosciences Inc., Seven Bridges Genomics Inc., Synthego Corp., Eurofins Genomics India Pvt. Ltd., Fabric Genomics Inc., Strand Life Sciences Pvt. Ltd., Admera Health LLC, Congenica Ltd., DNASTAR Inc., Golden Helix Inc., Geneious, SciGenom Labs Pvt. Ltd., Partek Incorporated, PathoQuest SAS, BioDatomics Inc., BGI Genomics Co. Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19614&type=smp

What Is Covered In The Next-Generation Sequencing Data Analysis Global Market Report?

•Market Size Forecast: Examine the next-generation sequencing data analysis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the next-generation sequencing data analysis market for a structured understanding.
•Key Players Overview: Analyze major players in the next-generation sequencing data analysis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the next-generation sequencing data analysis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the next-generation sequencing data analysis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the next-generation sequencing data analysis market.
•Industry Challenges: Identify potential risks and obstacles affecting the next-generation sequencing data analysis market.
•Competitive Landscape: Review strategic developments in the next-generation sequencing data analysis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.